JP2023542301A5 - - Google Patents

Info

Publication number
JP2023542301A5
JP2023542301A5 JP2023516505A JP2023516505A JP2023542301A5 JP 2023542301 A5 JP2023542301 A5 JP 2023542301A5 JP 2023516505 A JP2023516505 A JP 2023516505A JP 2023516505 A JP2023516505 A JP 2023516505A JP 2023542301 A5 JP2023542301 A5 JP 2023542301A5
Authority
JP
Japan
Prior art keywords
adc
cancer
cell
antibody
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023516505A
Other languages
English (en)
Japanese (ja)
Other versions
JP7829563B2 (ja
JP2023542301A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/075116 external-priority patent/WO2022053685A2/en
Publication of JP2023542301A publication Critical patent/JP2023542301A/ja
Publication of JP2023542301A5 publication Critical patent/JP2023542301A5/ja
Application granted granted Critical
Publication of JP7829563B2 publication Critical patent/JP7829563B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023516505A 2020-09-12 2021-09-13 抗b7h4抗体薬物コンジュゲート療法のためのスコア化方法 Active JP7829563B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063077607P 2020-09-12 2020-09-12
US63/077,607 2020-09-12
PCT/EP2021/075116 WO2022053685A2 (en) 2020-09-12 2021-09-13 A scoring method for an anti-b7h4 antibody-drug conjugate therapy

Publications (3)

Publication Number Publication Date
JP2023542301A JP2023542301A (ja) 2023-10-06
JP2023542301A5 true JP2023542301A5 (https=) 2024-09-12
JP7829563B2 JP7829563B2 (ja) 2026-03-13

Family

ID=77913114

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023516505A Active JP7829563B2 (ja) 2020-09-12 2021-09-13 抗b7h4抗体薬物コンジュゲート療法のためのスコア化方法

Country Status (9)

Country Link
US (1) US20240302348A1 (https=)
EP (1) EP4211663B1 (https=)
JP (1) JP7829563B2 (https=)
KR (1) KR20230066095A (https=)
CN (1) CN116615455A (https=)
AU (1) AU2021342349B2 (https=)
CA (1) CA3194182A1 (https=)
IL (1) IL301264A (https=)
WO (1) WO2022053685A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115160403B (zh) * 2022-07-05 2025-06-27 博石丰生命科技(南通)有限公司 特异性拓扑异构酶抑制剂和可用于抗体药物偶联物及其制备方法

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US6492107B1 (en) 1986-11-20 2002-12-10 Stuart Kauffman Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
DE229046T1 (de) 1985-03-30 1987-12-17 Marc Genf/Geneve Ballivet Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren.
US5618920A (en) 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
DE3600905A1 (de) 1986-01-15 1987-07-16 Ant Nachrichtentech Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
CA2016841C (en) 1989-05-16 1999-09-21 William D. Huse A method for producing polymers having a preselected activity
AU652539B2 (en) 1989-05-16 1994-09-01 Medical Research Council Co-expression of heteromeric receptors
CA2016842A1 (en) 1989-05-16 1990-11-16 Richard A. Lerner Method for tapping the immunological repertoire
US6172197B1 (en) 1991-07-10 2001-01-09 Medical Research Council Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
CA2095633C (en) 1990-12-03 2003-02-04 Lisa J. Garrard Enrichment method for variant proteins with altered binding properties
PT1024191E (pt) 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
EP0571613B1 (en) 1991-12-13 2003-09-17 Xoma Corporation Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
ES2176484T3 (es) 1995-08-18 2002-12-01 Morphosys Ag Bancos de proteinas/(poli)peptidos.
US7264963B1 (en) 1995-08-18 2007-09-04 Morphosys Ag Protein(poly)peptide libraries
US5714352A (en) 1996-03-20 1998-02-03 Xenotech Incorporated Directed switch-mediated DNA recombination
WO2001002588A2 (en) 1999-07-02 2001-01-11 Morphosys Ag Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests
US7538195B2 (en) 2002-06-14 2009-05-26 Immunogen Inc. Anti-IGF-I receptor antibody
ZA200503075B (en) 2002-11-07 2006-09-27 Immunogen Inc Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same
ATE460668T1 (de) * 2005-03-30 2010-03-15 Purdue Research Foundation Verfahren zur prognose von brustkrebs mittels quantifizierung von zellulären folat vitamin rezeptoren
CL2008003526A1 (es) 2007-11-30 2010-01-11 Medarex Inc Conjugado de anticuerpo-molécula asociada que comprende un anticuerpo monoclonal humano anti b7-h4/08e/b7x/b7s1/bl-cam/b3/leu-14/lyb-8 humana; composición que lo comprende; método in vitro de inhibición de célula tumoral que expresa b7-h4/08e/b7x/b7s1/bl-cam/b3/leu-14/lyb-8; y uso para tratar cancer.
JP5470817B2 (ja) 2008-03-10 2014-04-16 日産自動車株式会社 電池用電極およびこれを用いた電池、並びにその製造方法
JP5900489B2 (ja) * 2011-03-25 2016-04-06 コニカミノルタ株式会社 免疫組織染色法、およびこれを用いた抗体医薬の有効性を判定する方法
BR112013025415B1 (pt) * 2011-04-01 2021-03-16 Immunogen, Inc uso de um imunoconjugado antirreceptor de folato 1 (folr1)
US9676854B2 (en) 2011-08-15 2017-06-13 Medimmune, Llc Anti-B7-H4 antibodies and their uses
JP5712396B2 (ja) * 2012-03-30 2015-05-07 公益財団法人神奈川科学技術アカデミー イメージングセルソーター
JP6136279B2 (ja) 2013-01-15 2017-05-31 株式会社ジェイテクト 転がり軸受装置
JP6436965B2 (ja) 2013-03-14 2018-12-12 ジェネンテック, インコーポレイテッド 抗b7−h4抗体及びイムノコンジュゲート
TWI503850B (zh) 2013-03-22 2015-10-11 Polytronics Technology Corp 過電流保護元件
TWI510996B (zh) 2013-10-03 2015-12-01 Acer Inc 控制觸控面板的方法以及使用該方法的可攜式電腦
WO2015124777A1 (en) * 2014-02-21 2015-08-27 Ventana Medical Systems, Inc. Medical image analysis for identifying biomarker-positive tumor cells
US10613092B2 (en) * 2016-04-01 2020-04-07 Agilent Technologies, Inc. Scoring methods for anti-PD therapy eligibility and compositions for performing same
SI3626273T1 (sl) 2016-05-17 2021-04-30 Abbvie Biotherapeutics Inc. Konjugati protitelesa proti CMET in zdravila ter postopki za njihovo uporabo
US9816280B1 (en) 2016-11-02 2017-11-14 Matthew Reitnauer Portable floor
CN109906469B (zh) 2016-11-10 2023-11-21 豪夫迈·罗氏有限公司 基于距离的肿瘤分类
WO2019197509A1 (en) 2018-04-13 2019-10-17 Ventana Medical Systems, Inc. Systems for cell shape estimation
US11030744B2 (en) * 2018-06-26 2021-06-08 Astrazeneca Computational Pathology Gmbh Deep learning method for tumor cell scoring on cancer biopsies
US12020493B2 (en) 2018-07-27 2024-06-25 Ventana Medical Systems, Inc. Systems for automated in situ hybridization analysis
CN112868024B (zh) * 2018-10-15 2025-11-25 文塔纳医疗系统公司 用于细胞分类的系统和方法
US20230072897A1 (en) * 2019-06-06 2023-03-09 Shanghai Hansoh Biomedical Co., Ltd. Anti-b7-h4 antibody-drug conjugate and medicinal use thereof

Similar Documents

Publication Publication Date Title
JP2023545359A5 (https=)
US20220119545A1 (en) Cdcp1-targeted therapies
WO2012047317A2 (en) Tumor specific antibodies and uses therefor
CN117980007A (zh) c-KIT阳性肿瘤特异性抗体片段
US10947316B2 (en) Antibody-drug conjugates containing anti-Globo H antibodies and uses thereof
AU2021340002B9 (en) A scoring method for an anti-her2 antibody-drug conjugate therapy
JP7105304B2 (ja) 尿路上皮がんの治療における抗her2抗体-薬物コンジュゲートの使用
US11851496B2 (en) Antibodies against the human fshr extracellular domain
BR112020001657A2 (pt) Anticorpo contra cd147 humana, fragmento de ligação a antígeno do anticorpo, composição farmacêutica, uso do anticorpo ou do fragmento de ligação a antígeno,polinucleotídeo, vetor de expressão, célula hospedeira, método para produzir o anticorpo ou o fragmento de ligação a antígeno do mesmo, para prognosticar aresponsividade ao tratamento contra o câncer e para selecionar sujeitos para o tratamento contra o câncer, kit para determinar a responsividade ao tratamento contra o câncer, complexo de anticorpo-fármaco, e, anticorpo biespecífico
WO2023131193A1 (zh) 靶向人b7-h3分子的人源化单克隆抗体及其应用
US20230383357A1 (en) Subject-specific treatments for venetoclax-resistant acute myeloid leukemia
EP4198054A1 (en) Anti-hmmw antibody, composition containing same, nucleic acid molecule encoding same, and use thereof
JP2023542301A5 (https=)
JP2025509564A5 (https=)
JP2025509564A (ja) 抗trop2抗体-薬物コンジュゲート治療のためのスコアリング方法
AU2019228339A1 (en) Progastrin as a biomarker for immunotherapy
CN116920112A (zh) Icam1或其编码基因在制备胃癌治疗或诊断产品中的用途
Kaczmar et al. Phase 2 trial of nivolumab, an anti-PD-1 monoclonal antibody, as a novel neoadjuvant pre-surgical therapy for locally advanced oral cavity cancer
CN120053679A (zh) 一种靶向CD66c的抗体偶联药物及其在制备胃食管结合部癌治疗药物中的用途
JP2025528148A (ja) クローディン-6抗体及びそのコンジュゲート及び使用
WO2025095142A1 (ja) 光免疫療法
Chen Application of Engineered Fully Human Monoclonal Antibodies in Tumor Treatment and Diagnosis
WO2026052046A1 (zh) 抗Claudin18.2抗体药物偶联物用于治疗胃癌和/或胃食管结合部腺癌的用途
CN117159711A (zh) 一种抗体偶联物及其制备方法和在制备近红外光免疫疗法用药物中的用途
WO2025167716A1 (zh) 抗间皮素抗体药物偶联物治疗癌症的方法